Here Is My Top Stock Pick Among the Weight Loss Industry Leaders

The new generation of effective weight loss drugs has generated billions of dollars for industry leaders Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), and opened the door for companies such as Viking Therapeutics and Amgen that are working on rival new candidates.The growth of this healthcare niche looks to be far from over: While the weight loss drug segment is expected to be worth $28 billion this year, Goldman Sachs Research predicts that it may be worth $95 billion by the end of the decade.That's why, even though the stock prices of prominent companies in the niche have climbed in recent years, some still may have plenty of room to run. Among the weight loss movers and shakers, I expect one in particular to lead the way. Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool